Shenglin Ma Selected Research

capilliposide C

1/2021

Capilliposide C from Lysimachia capillipes Restores Radiosensitivity in Ionizing Radiation-Resistant Lung Cancer Cells Through Regulation of ERRFI1/EGFR/STAT3 Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shenglin Ma Research Topics

Disease

53	Neoplasms (Cancer) 06/2022 - 06/2009
47	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2007
33	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2010
15	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2009
11	Disease Progression 01/2021 - 11/2008
10	Adenocarcinoma of Lung 01/2022 - 08/2008
10	Hyperthermia 01/2019 - 01/2011
7	Stomach Neoplasms (Stomach Cancer) 12/2019 - 11/2008
5	Ovarian Neoplasms (Ovarian Cancer) 05/2018 - 06/2009
4	Diarrhea 01/2022 - 03/2014
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018 - 06/2014
3	Hypoxia (Hypoxemia) 05/2021 - 10/2014
3	Inflammation (Inflammations) 01/2021 - 01/2017
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2017
3	Brain Neoplasms (Brain Tumor) 01/2021 - 11/2012
3	Asthma (Bronchial Asthma) 01/2019 - 11/2016
3	Carcinoma (Carcinomatosis) 05/2018 - 11/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 11/2018
2	Liver Diseases (Liver Disease) 01/2022 - 03/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2015
2	Esophagitis 11/2019 - 09/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2019 - 01/2013
2	Respiratory Hypersensitivity 01/2019 - 01/2017
2	Lymphoma (Lymphomas) 11/2018 - 05/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018 - 01/2018
2	Malignant Pleural Effusion 01/2018 - 05/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016 - 05/2010
2	Exanthema (Rash) 03/2014 - 05/2012
2	Ovarian Epithelial Carcinoma 04/2013 - 06/2009
2	Pneumonia (Pneumonitis) 09/2012 - 05/2012
1	Adenocarcinoma 01/2022
1	Bites and Stings (Sting) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Glioma (Gliomas) 12/2021
1	Oral Ulcer (Mouth Ulcer) 11/2021
1	Esophageal Neoplasms (Esophageal Cancer) 05/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2009
14	ErbB Receptors (EGF Receptor)IBA 01/2022 - 03/2014
12	Gefitinib (Iressa)FDA Link 01/2021 - 08/2009
10	Tyrosine Kinase InhibitorsIBA 01/2020 - 03/2014
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
6	Pharmaceutical PreparationsIBA 01/2021 - 03/2014
6	Messenger RNA (mRNA)IBA 01/2019 - 06/2009
5	Vorinostat FDA Link 02/2021 - 01/2013
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 09/2010
5	Therapeutic UsesIBA 01/2021 - 11/2011
5	PlatinumIBA 01/2021 - 11/2008
5	Caspase 3 (Caspase-3)IBA 11/2018 - 06/2014
4	RNA (Ribonucleic Acid)IBA 06/2022 - 09/2010
4	osimertinibIBA 01/2022 - 01/2018
4	Histone Deacetylase InhibitorsIBA 02/2021 - 01/2013
4	Pemetrexed (MTA)FDA Link 01/2021 - 06/2011
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 09/2014
4	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 04/2013
4	Gemcitabine FDA Link 11/2018 - 08/2008
3	licogliflozinIBA 01/2022 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2016
3	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 06/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 06/2009
3	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 11/2018 - 01/2015
2	Docetaxel (Taxotere)FDA Link 01/2022 - 11/2008
2	AZD3759IBA 01/2022 - 12/2021
2	Circular RNAIBA 11/2021 - 01/2021
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 05/2015
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2021 - 11/2009
2	Bevacizumab (Avastin)FDA Link 01/2021 - 12/2019
2	SodiumIBA 01/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2021 - 11/2009
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 05/2015
2	Monoclonal AntibodiesIBA 12/2019 - 02/2014
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 01/2017
2	RetinoidsIBA 01/2019 - 11/2017
2	Interleukin-4 (Interleukin 4)IBA 01/2019 - 01/2017
2	CytokinesIBA 01/2019 - 01/2017
2	Interleukin-5 (Interleukin 5)IBA 01/2019 - 01/2017
2	Caspase 9IBA 11/2018 - 06/2017
2	VimentinIBA 01/2018 - 01/2017
2	Small Interfering RNA (siRNA)IBA 01/2018 - 09/2010
2	Radiation-Sensitizing AgentsIBA 01/2018 - 03/2015
2	Long Noncoding RNAIBA 05/2017 - 09/2015
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2016 - 01/2015
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2016 - 01/2011
2	polyphyllin DIBA 01/2015 - 06/2014
2	StathminIBA 04/2013 - 06/2009
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2022
1	Janus KinasesIBA 12/2021
1	Ointments (Pastes)IBA 11/2021

Therapy/Procedure

30	Radiotherapy 01/2022 - 05/2007
29	Drug Therapy (Chemotherapy) 01/2022 - 05/2007
27	Therapeutics 01/2022 - 11/2008
3	Chemoradiotherapy 11/2019 - 06/2011
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2018 - 01/2015
3	Cytoreduction Surgical Procedures 01/2015 - 06/2009
2	Immunotherapy 01/2022 - 01/2021
2	Oral Administration 01/2021 - 01/2019
2	Aftercare (After-Treatment) 10/2019 - 05/2017
1	Adjuvant Radiotherapy 01/2022